BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 267507)

  • 1. Antimetaboliths in the prophylaxis and treatment of central nervous system leukemia.
    Haghbin M
    Cancer Treat Rep; 1977 Jul; 61(4):661-6. PubMed ID: 267507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preventive therapy of the central nervous system complications in acute leukemias. Preliminary report.
    Gingold N; Butoianu E; Nicoară S
    Med Interne; 1978; 16(3):291-6. PubMed ID: 279080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
    Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
    Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
    Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
    Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
    Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E
    Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic CNS therapy in childhood acute leukemia: review of methods used.
    Pochedly C
    Am J Pediatr Hematol Oncol; 1979; 1(2):119-26. PubMed ID: 396796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
    Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
    Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Ommaya reservoir in the prevention and treatment of CNS leukemia.
    Haghbin M; Galicich JH
    Am J Pediatr Hematol Oncol; 1979; 1(2):111-7. PubMed ID: 317416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of prophylactic treatment of central nervous system leukemia in children. Analysis of CNS prophylactic treatment with cyclic high dose multichemotherapy, craniospinal irradiation, and high dose infusion of MTX].
    Abe Y; Asakura A; Endo N
    Gan To Kagaku Ryoho; 1982 May; 9(5):855-65. PubMed ID: 6964040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A; Ishii E; Ueda K; Yanai F; Nibu K; Take H; Koga H; Miyazaki S; Inoue T; Miyake K
    Rinsho Ketsueki; 1994 Sep; 35(9):862-70. PubMed ID: 7967055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center].
    de Diego-Floreschapa J; López-Hernández M; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
    Gac Med Mex; 1999; 135(3):253-8. PubMed ID: 10425822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone.
    Gingrich RD; Armitage JO; Burns CP
    Cancer Treat Rep; 1978 Sep; 62(9):1389-91. PubMed ID: 356988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
    Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
    Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children.
    Freeman AI; Weinberg V; Brecher ML; Jones B; Glicksman AS; Sinks LF; Weil M; Pleuss H; Hananian J; Burgert EO; Gilchrist GS; Necheles T; Harris M; Kung F; Patterson RB; Maurer H; Leventhal B; Chevalier L; Forman E; Holland JF
    N Engl J Med; 1983 Mar; 308(9):477-84. PubMed ID: 6571946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).
    Morra E; Lazzarino M; Alessandrino EP; Inverardi D; Regazzi Bonora M; Pagnucco G; Orlandi E; Bernasconi P; Canevari A; Rondanelli R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():101-3. PubMed ID: 2713552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
    Pinkerton CR; Chessells JM
    Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensification of the initial treatment in acute lymphoblastic leukemias of middle and high risk in children].
    Ortega Aramburu JJ; Javier Manchón G; Olivé Oliveras T; Montagut Dueso JM; Acebedo Lerzundi G; Torán Fuentes N
    An Esp Pediatr; 1989 Feb; 30(2):109-15. PubMed ID: 2655513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.